No 'one size fits all' treatment for type 1 diabetes, study finds
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery ...
Science Daily5d
No 'one size fits all' treatment for Type 1 Diabetes
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study ...
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring ...
FierceBiotech5d
Embecta shutters newly cleared insulin patch pump program amid layoffs, restructuring
Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...
News Medical6d
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...